Overview

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the activity and feasibility of a two drug regimen which is partly orally and partly intravenous in advanced pleural mesothelioma.
Phase:
Phase 2
Details
Lead Sponsor:
Rigshospitalet, Denmark
Treatments:
Carboplatin
Vinblastine
Vinorelbine